Clinical Trial Update: Panitumumab With or Without Trametinib in Treating Patients With Stage IV Colorectal Cancer [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating panitumumab with or without trametinib in Stage IV colorectal cancer; the study is currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Panitumumab (panitumumab)
• Trametinib (trametinib)

Snippet

Sponsor: M.D. Anderson Cancer Center | Conditions: EGFR NP_005219.2:p.S492R, KRAS Gene Mutation | Phase 2 | Status: ACTIVE_NOT_RECRUITING